178 related articles for article (PubMed ID: 31138731)
1. Bioavailability of Beclometasone From Two HFA-BDP Formulations With a Spacer.
Said AS; AbuRuz S; Chrystyn H
Respir Care; 2019 Oct; 64(10):1222-1230. PubMed ID: 31138731
[TBL] [Abstract][Full Text] [Related]
2. Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate.
Said AS; Harding LP; Chrystyn H
Br J Clin Pharmacol; 2012 Sep; 74(3):456-64. PubMed ID: 22299644
[TBL] [Abstract][Full Text] [Related]
3. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
Leach CL; Colice GL
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.
Rony F; Cortellini M; Guasconi A; Mathews KS; Piccinno A; Poli G; Vanhoutte F; Klein J
Pulm Pharmacol Ther; 2024 Jun; 85():102299. PubMed ID: 38663512
[TBL] [Abstract][Full Text] [Related]
5. Local versus total systemic bioavailability of beclomethasone dipropionate CFC and HFA metered dose inhaler formulations.
Harrison LI
J Aerosol Med; 2002; 15(4):401-6. PubMed ID: 12581506
[TBL] [Abstract][Full Text] [Related]
6. Comparison of beclomethasone dipropionate delivery by easyhaler dry powder inhaler and pMDI plus large volume spacer.
Newman SP; Pitcairn GR; Adkin DA; Vidgren MT; Silvasti M
J Aerosol Med; 2001; 14(2):217-25. PubMed ID: 11681653
[TBL] [Abstract][Full Text] [Related]
7. Modulite technology: pharmacodynamic and pharmacokinetic implications.
Woodcock A; Acerbi D; Poli G
Respir Med; 2002 Aug; 96 Suppl D():S9-15. PubMed ID: 12201080
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers.
Poli G; Acerbi D
Respir Med; 2003 Feb; 97 Suppl B():S5-9. PubMed ID: 12593521
[TBL] [Abstract][Full Text] [Related]
9. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ
Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[TBL] [Abstract][Full Text] [Related]
12. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD; Walters EG
Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic properties of inhaled beclometasone dipropionate delivered via hydrofluoroalkane-containing devices.
Derom E; Pauwels RA
Clin Pharmacokinet; 2005; 44(8):815-36. PubMed ID: 16029067
[TBL] [Abstract][Full Text] [Related]
14. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
Seale JP; Harrison LI
Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
[TBL] [Abstract][Full Text] [Related]
15. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler.
Dhillon S; Keating GM
Drugs; 2006; 66(11):1475-83; discussion 1484-5. PubMed ID: 16906779
[TBL] [Abstract][Full Text] [Related]
16. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler.
Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
J Aerosol Med; 2005; 18(4):379-85. PubMed ID: 16379614
[TBL] [Abstract][Full Text] [Related]
17. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model.
Janssens HM; De Jongste JC; Hop WC; Tiddens HA
Chest; 2003 Jun; 123(6):2083-8. PubMed ID: 12796192
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
Vanden Burgt JA; Busse WW; Martin RJ; Szefler SJ; Donnell D
J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
[TBL] [Abstract][Full Text] [Related]
19. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ; Orr LC; Wilson AM; Sims EJ; Lipworth BJ
Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
Gillissen A; Richter A; Oster H; Criée CP
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
